UPADACITINIB 30 mg (Upadoz) × 30 Tablets

Name: Upadacitinib 30 mg (Upadoz) × 30 Tablets
Brand: Upadoz
Price: 130.00 USD
Availability: InStock

~~$240.00~~ $130.00

Prescription Required

Upadacitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. It is prescribed for selected inflammatory conditions affecting the joints, skin or bowel when other treatments are unsuitable or have not provided adequate control.

Generic Name	Upadacitinib
Strength	30 mg
Manufacturer	MSN Laboratories Private Limited
Packing	30 Tablets
Prescribed For	Suppresses an overactive immune system to treat chronic inflammatory and autoimmune conditions
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Uses of Upadacitinib

Rheumatoid or psoriatic arthritis
Atopic dermatitis
Ulcerative colitis
Crohn’s disease
Axial spondyloarthritis

Benefits of Upadacitinib

Reduces inflammation
Relieves joint, skin and bowel symptoms
May help achieve disease control

How Does Upadacitinib Work?

Upadacitinib blocks enzymes called Janus kinases, or JAKs, which transmit inflammatory signals within the immune system. By interrupting these signals, it reduces excessive immune activity, inflammation and tissue damage. This can help relieve joint, skin and bowel symptoms.

Possible Side Effects

Upper respiratory infections
Acne
Nausea
Headache
Increased cholesterol
Abnormal liver tests

Precautions

Screening for tuberculosis and hepatitis may be required.
It can increase the risk of infections and blood clots.
Blood counts and liver function should be monitored.
Avoid live vaccines and pregnancy.
Discuss cardiovascular or cancer risk factors with your doctor.

Upadacitinib Price and Reimbursement Information by Country

Upadacitinib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

View medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/upadacitinib/medicinal-forms/
View Upadacitinib medicine information on Drugs.com (USA) – https://www.drugs.com/upadacitinib.html
View PBS information for the 30 mg modified-release tablet (Australia) – https://www.pbs.gov.au/medicine/item/12827D
View current Rinvoq prescribing information on DailyMed (USA) – https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=RINVOQ

Author

Reviewed By

Dr. Anjali Desai

Doctor of Medicine (MD) | Professional Interest in Rheumatoid Arthritis and Joint Care

Dr. Anjali Desai holds a Doctor of Medicine (MD) degree and has a professional interest in rheumatoid arthritis and joint care. Her interests include managing symptoms, monitoring disease progression, supporting treatment plans and improving patients’ quality of life.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.